Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: A qualitative study

Quality and Safety in Health Care

Volumn 16, Issue 2, 2007, Pages 143-149

  Schouten, Jeroen A ^a   Hulscher, Marlies E J L ^a   Natsch, Stephanie ^a   Kullberg, Bart Jan ^a   Van Der Meer, Jos W M ^a   Grol, Richard P T M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; ERYTHROMYCIN; PENICILLIN G;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HUMAN; MALE; PRACTICE GUIDELINE; PRESCRIPTION; QUALITATIVE RESEARCH; SPUTUM CULTURE; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; GUIDELINE ADHERENCE; HUMANS; INTERVIEWS; PHYSICIAN'S PRACTICE PATTERNS; PNEUMONIA; QUALITATIVE RESEARCH;

EID: 34247112769     PISSN: 14753898     EISSN: None     Source Type: Journal    
DOI: 10.1136/qshc.2005.017327     Document Type: Article

References (31)

1. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax 2001;56(Suppl 4):iv1-64.
2. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000;31:347-82.
3. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730-54.
4. van Kasteren ME, Wijnands WJ, Stobberingh EE, et al. [Optimization of the antibiotics policy in the Netherlands. II. SWAB guidelines for the antimicrobial therapy of pneumonia in patients at home and as nosocomial infections. The Netherlands Antibiotic Policy Foundation]. Ned Tijdschr Geneeskd 1998;142:952-6.
5. Menendez R, Ferrando D, Valles JM, et al. Influence of deviation from guidelines on the outcome of community-acquired pneumonia. Chest 2002;122:612-17.
6. Malone DC, Shaban HM. Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia. Ann Pharmacother 2001;35:1180-5.
7. Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004;164:637-44.
8. Chu LA, Bratzler DW, Lewis RJ, et al. Improving the quality of care for patients with pneumonia in very small hospitals. Arch Intern Med 2003;163:326-32.
9. Halm EA, Horowitz C, Silver A, et al. Limited impact of a multicenter intervention to improve the quality and efficiency of pneumonia care. Chest 2004;126:100-7.
10. Simpson SH, Marrie TJ, Majumdar SR. Do guidelines guide pneumonia practice? A systematic review of interventions and barriers to best practice in the management of community-acquired pneumonia. Respir Care Clin N Am 2005;11:1-13.
11. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet 2003;362:1225- 30.
12. Tunis SR, Hayward RS, Wilson MC, et al. Internists' attitudes about clinical practice guidelines. Ann Intern Med 1994;120:956-63.
13. Hayward RS, Wilson MC, Tunis SR, et al. Practice guidelines. What are internists looking for? J Gen Intern Med 1996;11:176-8.
14. Hayward RS, Guyatt GH, Moore KA, et al. Canadian physicians' attitudes about and preferences regarding clinical practice guidelines. CMAJ 1997;156:1715-23.
15. Vogtlander NP, van Kasteren ME, Natsch S, et al. Improving the process of antibiotic therapy in daily practice: interventions to optimize timing, dosage adjustment to renal function, and switch therapy. Arch Intern Med 2004;164:1206-12.
16. Switzer GE, Halm EA, Chang CC, et al. Physician awareness and self-reported use of local and national guidelines for community-acquired pneumonia. J Gen Intern Med 2003;18:816-23.
17. Majumdar SR, Simpson SH, Marrie TJ. Physician-perceived barriers to adopting a critical pathway tor unity-acquired pneumonia. Jt Comm J Qual Saf 2004;30:387-95.
18. Mol PG, Rutten WJ, Gans RO, et al. Adherence barriers to antimicrobial treatment guidelines in teaching hospital, the Netherlands. Emerg Infect Dis 2004;10:522-5.
19. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-65.
20. Grol R, Wensing M. What drives change? Barriers to and incentives for achieving evidence-based practice. Med J Aust 2004;180(Suppl 6):S57-S60.
21. Grol R, Baker R, Moss F. Quality improvement research: understanding the science of change in health care. London: BMJ Publishing Group, 2004.
22. Schouten JA, Hulscher ME, Wollersheim H, et al. Quality of antibiotic use for lower respiratory tract infections at hospitals: (how) can we measure it? Clin Infect Dis 2005;41:450-60.
23. Verheij TJ, Salome PL, Bindels PJ, et al. NHG-standaard Acuut hoesten. Huisarts en Wetenschap 2003;46:496-506.
24. Schouten JA, Hulscher ME, Natsch S, et al. Antibiotic control measures in Dutch secondary care hospitals. Neth J Med 2005;63:24-30.
25. Halm EA, Atlas SJ, Borowsky LH, et al. Change in physician knowledge and attitudes after implementation of a pneumonia practice guideline. J Gen Intern Med 1999;14:688-94.
26. Halm EA, Switzer GE, Mittman BS, et al. What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia? J Gen Intern Med 2001;16:599- 605.
27. van Bokhoven MA, Kok G, van der WT. Designing a quality improvement intervention: a systematic approach. Qual Saf Health Care 2003;12:215-220.
28. Bartholomew L, Kok G, Parcel G, et al. Intervention mapping: designing theory-and evidence-based health promotion programs. New York: McGraw Hill, 2001.
29. Oosterheert JJ, Bonten MJ, Hak E, et al. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review. J Antimicrob Chemother 2003;52:555-63.
30. Oosterheert JJ, Bonten MJ, Schneider MM, et al. [Community acquired pneumonia; no reason to revise current Dutch antibiotic guidelines]. Ned Tijdschr Geneeskd 2003;147:381-6.
31. Schouten JA, Hulscher ME, Kullberg BJ, et al. Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors. J Antimicrob Chemother 2005;56:575-82.